In vitro activity of pentacaine against Campylobacter pylori

Campylobacter pylori has been implicated as an etiological factor in gastritis and peptic ulcer diseases. The presence of these bacilli on the gastric mucosa is closely associated with histologically demonstrable gastritis. Twenty-five isolates of Campylobacter pylori were cultured from antral biops...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 1988-08, Vol.7 (4), p.579-579
Main Authors: Kubonova, K, Benes, L, Kettner, M
Format: Article
Language:English
Subjects:
Anesthetics, Local - pharmacology
Campylobacter - drug effects
Carbamates - pharmacology
Humans
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 579
container_issue 4
container_start_page 579
container_title European journal of clinical microbiology & infectious diseases
container_volume 7
creator Kubonova, K
Benes, L
Kettner, M
description Campylobacter pylori has been implicated as an etiological factor in gastritis and peptic ulcer diseases. The presence of these bacilli on the gastric mucosa is closely associated with histologically demonstrable gastritis. Twenty-five isolates of Campylobacter pylori were cultured from antral biopsy specimens obtained during routine endoscopy of patients with upper gastrointestinal symptoms (duodenal ulcer, bulbitis, gastritis, pyloritis). Pentacaine displayed moderate activity against Campylobacter pylori (MIC90 64 mg/l).
doi_str_mv 10.1007/BF01962620
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78498389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78498389</sourcerecordid><originalsourceid>FETCH-LOGICAL-p152t-4c119e188b7b1e9f75c6e2514720b0c7a3ad2c12e56054992f2de484595392253</originalsourceid><addsrcrecordid>eNqF0DtPwzAUBWAPoFIKCzuSJ7aArx-5tsQCFYVKlVhgjhznBgXlRZwg9d8TRHamc4ZPZziMXYG4BSHw7nEnwKUyleKErYVTOnEo1Rk7j_FTzMAirthKgQZAXLP7fcu_q3HouA9jNbcj70reUzv64KuWuP-YI45865v-WHf5zGjgv3WoLthp6etIl0tu2Pvu6W37khxen_fbh0PSg5FjogOAI7A2xxzIlWhCStKARilyEdArX8gAkkwqjHZOlrIgbbVxRjkpjdqwm7_dfui-Jopj1lQxUF37lropZmi1s8q6fyEYAQoRZni9wClvqMj6oWr8cMyWX9QPCltf_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15013771</pqid></control><display><type>article</type><title>In vitro activity of pentacaine against Campylobacter pylori</title><source>Springer LINK Archives</source><creator>Kubonova, K ; Benes, L ; Kettner, M</creator><creatorcontrib>Kubonova, K ; Benes, L ; Kettner, M</creatorcontrib><description>Campylobacter pylori has been implicated as an etiological factor in gastritis and peptic ulcer diseases. The presence of these bacilli on the gastric mucosa is closely associated with histologically demonstrable gastritis. Twenty-five isolates of Campylobacter pylori were cultured from antral biopsy specimens obtained during routine endoscopy of patients with upper gastrointestinal symptoms (duodenal ulcer, bulbitis, gastritis, pyloritis). Pentacaine displayed moderate activity against Campylobacter pylori (MIC90 64 mg/l).</description><identifier>ISSN: 0934-9723</identifier><identifier>DOI: 10.1007/BF01962620</identifier><identifier>PMID: 3141177</identifier><language>eng</language><publisher>Germany</publisher><subject>Anesthetics, Local - pharmacology ; Campylobacter - drug effects ; Carbamates - pharmacology ; Humans</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 1988-08, Vol.7 (4), p.579-579</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3141177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kubonova, K</creatorcontrib><creatorcontrib>Benes, L</creatorcontrib><creatorcontrib>Kettner, M</creatorcontrib><title>In vitro activity of pentacaine against Campylobacter pylori</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Campylobacter pylori has been implicated as an etiological factor in gastritis and peptic ulcer diseases. The presence of these bacilli on the gastric mucosa is closely associated with histologically demonstrable gastritis. Twenty-five isolates of Campylobacter pylori were cultured from antral biopsy specimens obtained during routine endoscopy of patients with upper gastrointestinal symptoms (duodenal ulcer, bulbitis, gastritis, pyloritis). Pentacaine displayed moderate activity against Campylobacter pylori (MIC90 64 mg/l).</description><subject>Anesthetics, Local - pharmacology</subject><subject>Campylobacter - drug effects</subject><subject>Carbamates - pharmacology</subject><subject>Humans</subject><issn>0934-9723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><recordid>eNqF0DtPwzAUBWAPoFIKCzuSJ7aArx-5tsQCFYVKlVhgjhznBgXlRZwg9d8TRHamc4ZPZziMXYG4BSHw7nEnwKUyleKErYVTOnEo1Rk7j_FTzMAirthKgQZAXLP7fcu_q3HouA9jNbcj70reUzv64KuWuP-YI45865v-WHf5zGjgv3WoLthp6etIl0tu2Pvu6W37khxen_fbh0PSg5FjogOAI7A2xxzIlWhCStKARilyEdArX8gAkkwqjHZOlrIgbbVxRjkpjdqwm7_dfui-Jopj1lQxUF37lropZmi1s8q6fyEYAQoRZni9wClvqMj6oWr8cMyWX9QPCltf_Q</recordid><startdate>198808</startdate><enddate>198808</enddate><creator>Kubonova, K</creator><creator>Benes, L</creator><creator>Kettner, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>198808</creationdate><title>In vitro activity of pentacaine against Campylobacter pylori</title><author>Kubonova, K ; Benes, L ; Kettner, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p152t-4c119e188b7b1e9f75c6e2514720b0c7a3ad2c12e56054992f2de484595392253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Anesthetics, Local - pharmacology</topic><topic>Campylobacter - drug effects</topic><topic>Carbamates - pharmacology</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kubonova, K</creatorcontrib><creatorcontrib>Benes, L</creatorcontrib><creatorcontrib>Kettner, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kubonova, K</au><au>Benes, L</au><au>Kettner, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro activity of pentacaine against Campylobacter pylori</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>1988-08</date><risdate>1988</risdate><volume>7</volume><issue>4</issue><spage>579</spage><epage>579</epage><pages>579-579</pages><issn>0934-9723</issn><abstract>Campylobacter pylori has been implicated as an etiological factor in gastritis and peptic ulcer diseases. The presence of these bacilli on the gastric mucosa is closely associated with histologically demonstrable gastritis. Twenty-five isolates of Campylobacter pylori were cultured from antral biopsy specimens obtained during routine endoscopy of patients with upper gastrointestinal symptoms (duodenal ulcer, bulbitis, gastritis, pyloritis). Pentacaine displayed moderate activity against Campylobacter pylori (MIC90 64 mg/l).</abstract><cop>Germany</cop><pmid>3141177</pmid><doi>10.1007/BF01962620</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 1988-08, Vol.7 (4), p.579-579
issn 0934-9723
language eng
recordid cdi_proquest_miscellaneous_78498389
source Springer LINK Archives
subjects Anesthetics, Local - pharmacology
Campylobacter - drug effects
Carbamates - pharmacology
Humans
title In vitro activity of pentacaine against Campylobacter pylori
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A47%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20activity%20of%20pentacaine%20against%20Campylobacter%20pylori&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Kubonova,%20K&rft.date=1988-08&rft.volume=7&rft.issue=4&rft.spage=579&rft.epage=579&rft.pages=579-579&rft.issn=0934-9723&rft_id=info:doi/10.1007/BF01962620&rft_dat=%3Cproquest_pubme%3E78498389%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p152t-4c119e188b7b1e9f75c6e2514720b0c7a3ad2c12e56054992f2de484595392253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15013771&rft_id=info:pmid/3141177&rfr_iscdi=true